L2P Research was founded in 2015 with a vision to provide integrated R&D support in all the key areas of Pre-clinical Research. After early struggles and hard work, firm now a fast growing Research organization in New york. With principals e-f the having firm years of experience in various areas of Pharmaceutical industry, Specialized in Preclinical development, GxPs compliance, Auditing and quality management. As a researcher at National cancer institute (NIH) and International agency for research in cancer (IARC- WHO), Dr. Anaganti envisioned establishing a research organization that conducts research with precision and integrity. Dr. Anaganti serves as technical reviewer for 'Quality progress' a prestigious journal published by American Society for Quality. We provide a complete array of research services as required for Investigational New Drug Applications (IND). L2P Research Labs at Stony Brook New York is fully committed to the judicious, humane use of animals in research and development. We operate in AAALAC accredited and GLP compliant audited facilities. We offer proprietary orthotopic and metastases tumor models. Our services include Efficacy studies, Immuno-oncology models, IND enabling GLP/Non-GLP studies, Whole Body Animal Imaging, small animal ultra sound MRI, PDX tumor models, CT scan and other advanced technologies.
